Encompass Health Corporation EHC

Healthcare · Medical Care Facilities · valued as of 2026-11-03 · statements 2025-12-31

Average Intrinsic Value
$8.81B
Market Cap
$11.76B
Margin of Safety
-33.5%
Intrinsic / Market Ratio
0.75

How Each Value Is Built

The screener's three formulas on the reported figures. Each card reads the same way: the value as a sum of numbered terms, each term's calculation opened under it, from the reported figures to the value. The list ranks companies by their plain average over the market cap.

EPV + Growth

8.94B USD

what the normal year's earnings are worth for ever, plus growth that pays

Profit

8.95B USD

15 years of cash the shareholders can take out, and the equity left at year 15

FCFF

8.52B USD

15 years of cash for shareholders and lenders, less what is owed

Intrinsic Value

8.81B USD

the plain average of the three, uncapped, as the screener averages them

Intrinsic Value

8.81B USD

from the sum above

Market Cap

11.76B USD

today's price times the shares

Intrinsic Value ÷ Market Cap

0.75×

the ratio the screener ranks by; Margin of Safety -33.5% (1 − Market Cap ÷ Intrinsic Value)

Each card below builds one of the three values from the reported years.

Earnings power value plus growth: 8.94B USD
What the normal year's operating profit after tax is worth if it lasts for ever, plus what the new investment adds beyond its cost, less the net debt that comes before the shareholders (or plus the net cash).
①EPV (earnings power value)10.30B USD
−②Net Debt Today2.74B USD
+③Growth Value1.38B USD
=Value8.94B USD

EPV of the Operations (NOPAT over WACC)

10.30B USD

Net debt today

-2.74B USD

Growth Value

+1.38B USD

Value

8.94B USD

①EPV (earnings power value)

10.30B USD

②Net Debt Today

2.74B USD

③Growth Value

1.38B USD

Market value

Market Cap11.76B USD

Today's price times the shares.

Value vs market

Margin of Safety-31.4%

1 minus the market cap as a share of the value.

Profit value: today's value of the shareholders' equity, from the cash it can pay them (FCFE): 8.95B USD
Fifteen years of free cash flow to equity (FCFE), each brought to today at the cost of equity, plus the equity at year 15 brought to today.
①Present Value of the 15 Years of FCFE5.41B USD
+②Equity at Year 15, Today3.54B USD
=Value8.95B USD
FCFE: the net income left for the shareholders once the business keeps what next year's growth needsEquity reinvestment: the part of the year's net income kept in the business to grow the next year; below zero, capital the business releases to the shareholdersPresent value of the FCFEColoured bars show the FCFE, grey bars the equity reinvestment. With a positive equity reinvestment the two stacked are the year's normalized income; with a negative one the grey is below zero, capital the business releases, and the normalized income is the FCFE plus that negative amount. Shaded, years 6 to 10: the growth falling to its long-run rate and the ROE on new investment falling to the cost of equity. Axes linear.

①Present Value of the 15 Years of FCFE

5.41B USD

②Equity at Year 15, Today

3.54B USD

Market value

Market Cap11.76B USD

Today's price times the shares.

Value vs market

Margin of Safety-31.4%

1 minus the market cap as a share of the value.

FCFF value: today's value of the shareholders' equity, from the cash the firm can pay its shareholders and lenders (FCFF): 8.52B USD
Fifteen years of free cash flow to the firm (FCFF), each brought to today at the WACC, plus the invested capital at year 15 brought to today, less the net debt today (or plus the net cash).
①Present Value of the 15 Years of FCFF6.79B USD
+②Invested Capital at Year 15, Today4.47B USD
−③Net Debt Today2.74B USD
=Value8.52B USD
FCFF: the NOPAT left for the shareholders and the lenders once the business reinvests what next year's growth needsReinvestment: the part of the year's NOPAT put back into the business to grow the next year; below zero, capital the business releasesPresent value of the FCFFColoured bars show the FCFF, grey bars the reinvestment. With a positive reinvestment the two stacked are the year's NOPAT; with a negative one the grey is below zero, capital the business releases, and the NOPAT is the FCFF plus that negative amount. Shaded, years 6 to 10: the growth falling to its long-run rate and the ROIC on new investment falling to the WACC. Axes linear.

①Present Value of the 15 Years of FCFF

6.79B USD

②Invested Capital at Year 15, Today

4.47B USD

③Net Debt Today

2.74B USD

Market value

Market Cap11.76B USD

Today's price times the shares.

Value vs market

Margin of Safety-38.0%

1 minus the market cap as a share of the value.

The Rates and the Capital the Values Read

The WACC and the cost of equity each value is discounted at, the book value and the net debt each starts from, and the seven quality metrics, from the same run.

WACC: 7.23%
weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.
Cost of Equity =Risk-Free Rate 4.50%+Beta 0.61×Market Risk Premium 6.00%= 8.15%

The yearly return the shareholders require for the risk they carry; it is the rate that brings their future cash to today.

Tax Rate for WACC =Tax Provision 193.09M USDPretax Income 953.95M USD= 20.24%

The tax the interest saves.

Interest Expense =EBIT 1.08B USD−Pretax Income 953.95M USD= 123.32M USD

The interest the company paid: EBIT is the profit before tax plus the interest.

Cost of Debt =Interest Expense 123.32M USDTotal Debt 2.85B USD×(1 − Tax Rate for WACC 20.24%)= 3.46%

What the lenders are paid a year after the tax the interest saves.

Debt Weight =Total Debt 2.85B USDMarket Cap + Total Debt 11.76B USD + 2.85B USD= 19.48%

The part of the capital the lenders put in, at market value.

WACC =Equity Weight 80.52%×Cost of Equity 8.15%+Debt Weight 19.48%×Cost of Debt 3.46%= 7.23%

Weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.

Book value and net debt today
Both from the balance sheet of the newest quarter, 2026-06-30.

Total Assets 7.46B USD − Total Liabilities 4.00B USD = Book Value Today 3.46B USD

Total Debt 2.85B USD − Cash and Short-Term Investments 107.81M USD = Net Debt Today 2.74B USD

The book value is what Profit starts from and what stands when a projection is not made; the book value plus the net debt is what FCFF starts from; the net debt comes off Greenwald's and FCFF's values before the shareholders.

Quality metrics
Read beside the value, never a condition for it: every company is valued, and a filter in the list is the reader's choice.
MetricFrom
Share dilutionShares Today ÷ Shares Two Years Back − 1-1.4%at most 5%passes98,800,000 / 100,252,767
Accrual quality(Operating Cash Flow − Net Income) ÷ Total Assets8.2%at least -10.0%passes(1.18B USD − 566.77M USD) ÷ 7.46B USD
Price to bookMarket Cap ÷ Book Value Today3.39×at most 3×does not pass11.76B USD ÷ 3.46B USD
Operating marginOperating Income ÷ Revenue17.7%above 10.0%passes1.05B USD ÷ 5.94B USD
Revenue growthRevenue ÷ Revenue a Year Before − 110.5%above 10.0%passes5.94B USD / 5.38B USD
Net cash(Cash − Total Debt) ÷ Market Cap-23.3%above -30%passes(107.81M USD − 2.85B USD) ÷ 11.76B USD
Operating efficiencyOperating Income ÷ Gross Profit18.5%above 25.0%does not pass1.05B USD ÷ 5.69B USD

Market Data

The provider's ratios and the analysts' consensus beside the argument; none of them enters a value.

Market data
The data provider's own ratios and the analysts' consensus, read beside the valuation, never in it.

Share price

119 USD

Enterprise value

15.36B USD

market cap plus net debt

EV / EBITDA

10.48×

Price / book

4.53×

the provider's book

Price / earnings

19.88×

Return on equity

25.0%

the provider's, not the engine's

Profit margin

10.0%

Revenue growth

9.6%

Analyst target, mean

148 USD

Analysts

12

opinions in the consensus

Financial Statements

The income statement, the balance sheet and the cash flow the screener holds, year by year, in USD.

Financial statements, year by year
The annual lines the screener holds today, in USD at each period's rate; the figures this valuation read are in its calculation above.
USD2022202320242025
Income statement

Revenue

4.35B4.81B5.38B5.94B

Gross profit

1.75B1.98B2.24B5.69B

Operating income

630.83M732.53M865.36M1.05B

EBITDA

operating income before depreciation and amortisation

870.97M1.03B1.19B1.41B

Pretax income

451.25M607.81M750.35M953.95M

Net income

271.27M352.35M456.16M566.77M

Normalized income

net income without one-off items, as the data provider prints it; Profit's line when printed

257.15M364.36M459.44M567.77M

R&D

————
Balance sheet, year end

Total assets

5.64B6.11B6.54B7.10B

Total liabilities

3.78B3.81B3.69B3.82B

Shareholders' equity

the equity the parent's shareholders own, as printed, without minority interest; the book value the values read is total assets less total liabilities, in Book Value and Net Debt above

1.31B1.65B2.07B2.44B

Total debt

3.00B2.94B2.72B2.72B

Cash and equivalents

21.82M69.17M85.49M72.27M

Net PP&E

fixed assets after depreciation

3.15B3.51B3.85B4.32B

Working capital

current assets less current liabilities

141.44M185.59M45.95M69.57M
Cash flow

Operating cash flow

706.51M851.65M1.00B1.18B

Capital expenditure

paid out, so below zero

-584.68M-583.68M-643.14M-737.14M

Depreciation and amortisation

243.84M274.17M299.90M328.23M

Free cash flow

operating cash flow plus capital expenditure

121.82M267.97M360.66M439.64M